Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript
May 2, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0.65387, expectations were $-0.8. Tandem Diabetes Care, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Why Tandem Diabetes Stock Just Jumped 22%
Tandem grew Q1 sales 13% year over year on a 9% increase in units shipped. Curiously, Tandem showed its greatest growth -- 67% -- in units sold outside the U.S., while U.S. shipments declined 12%. That translated into only a 1% decline in U.S. revenue, however, while ex-U.S. sales surged 63%.
A new study found a correlation between avocado consumption and reduced diabetes risk in Mexican adults. Several dietitians ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tandem Diabetes Care (TNDM – Research ...
In today’s healthcare landscape, value-based outcomes are more than a trending topic; they’re a primary goal. And for individuals living with diabetes, value-based outcomes are the key to a healthy ...
A study in a primarily Hispanic population points to the need for improved communication between patients and providers.
The 12-month price targets, analyzed by analysts, offer insights with an average target of $34.0, a high estimate of $40.00, ...
A new WhatsApp group run by fully qualified NHS workers from Bradford is helping people with diabetes care. The group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results